Tenderfy

Ono type DX Breast Recurrence Score Test

Buyer
Leeds Teaching Hospitals NHS Trust
Published
2026-10-26
Deadline
2026-06-30T11:00:00+00:00
Sources
UK_CF
Value
405000.0 GBP

Description

The description is in the source language.

Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.

CPV: 85111800

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read